Treatment of cerebral glioblastoma-caused bruxism with mirtazapine: a case report

BACKGROUND: Bruxism refers to grind or gnash the opposing rows of upper and lower molar teeth. It is important to treat bruxism as a factor that can influence sleep quality, quality of life, and mental status in patients with malignancy. CASE PRESENTATION: A 41-year-old male developed bruxism second...

Descripción completa

Detalles Bibliográficos
Autor principal: Khosravi, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085486/
https://www.ncbi.nlm.nih.gov/pubmed/32200532
http://dx.doi.org/10.1186/s40981-020-00329-4
Descripción
Sumario:BACKGROUND: Bruxism refers to grind or gnash the opposing rows of upper and lower molar teeth. It is important to treat bruxism as a factor that can influence sleep quality, quality of life, and mental status in patients with malignancy. CASE PRESENTATION: A 41-year-old male developed bruxism secondary to cerebral glioblastoma. l-dopa, gabapentin, clonazepam, clonidine, baclofen, buspirone, or propranolol were not effective. Mirtazapine, prescribed for side effects of chemotherapy, was effective for bruxism, which was disappeared within 3 weeks. CONCLUSIONS: Mirtazapine was effective for treating bruxism as well as chemotherapy complications.

Ejemplares similares